SB17170 Phase1 Trial in Healthy Volunteer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This clinical trial aims to learn about the safety, tolerability, and pharmacokinetic properties of SB17170 and its active metabolite SB1703 in single and multiple oral administration in healthy adults. The main questions it aims to answer are the safety, tolerability, and PK characteristics of SB17170 in healthy adults.
Epistemonikos ID: f20af878c663025c30096ca5e7d6c18c4bdd68ca
First added on: Feb 19, 2024